← Open Payments lookup

DANIEL NIKNAM: Open Payments

NPI 1598262073 · INGLEWOOD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,826 in 77 payments from 21 companies in 2025. Trend: 2023 $1,073 · 2024 $1,367 · 2025 $1,826

Food & beverage: $1,783Education: $43
CompanyPaymentsAmount
GlaxoSmithKline, LLC.25$533
Lundbeck LLC9$242
Bayer Healthcare Pharmaceuticals Inc.7$174
Electromed, Inc.6$80
Actelion Pharmaceuticals US, Inc.3$79
GENZYME CORPORATION2$78
Boehringer Ingelheim Pharmaceuticals, Inc.2$67
Aimmune Therapeutics, Inc.2$59
E.R. Squibb & Sons, L.L.C.3$57
Insmed, Inc.2$55

Products named: NUCALA, REXULTI, TRELEGY ELLIPTA, Kerendia, SMARTVEST, DUPIXENT, OFEV, VOWST.

Industry payments across CA — which companies pay providers there.